Sabatier R, Gonçalves A, Bertucci F: Personalized medicine: present and future of breast cancer management. Crit Rev Oncol Hematol 2014, 91(3):223-233.
 Chaffer CL, Weinberg RA: A perspective on cancer cell metastasis. Science 2011, 331(6024):1559-1564.
 Jones PA: DNA methylation and cancer. Oncogene 2002, 21(35):5358-5360.
 Kastl L, Brown I, Schofield AC: Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells. International journal of oncology 2010, 36(5):1235-1241.
 Rajabi H, Tagde A, Alam M, Bouillez A, Pitroda S, Suzuki Y, et al: DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells. Oncogene 2016, 35(50):6439-6445.
 Zhang W, Chang Z, Shi KE, Song L, Cui LI, Ma Z, et al: The correlation between DNMT1 and ERα expression and the methylation status of ERα, and its clinical significance in breast cancer. Oncology letters 2016, 11(3):1995-2000.
 Singh V, Sharma P, Capalash N: DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer. Curr Cancer Drug Targets 2013, 13(4):379-399.
 Li Z, Li Y, Li Y, Ren K, Li X, Han X, et al: Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152. J Biochem Mol Toxicol 2017, 31(9):10.1002/jbt.21933.
 Wang X-X, Guo G-C, Qian X-K, Dou D-W, Zhang Z, Xu X-D, et al: miR-506 attenuates methylation of lncRNA MEG3 to inhibit migration and invasion of breast cancer cell lines via targeting SP1 and SP3. Cancer cell international 2018, 18:171-171.
 Zhou Y, Zhang X, Klibanski A: MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol 2012, 48(3):R45-R53.
 Sun L, Li Y, Yang B: Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity. Biochemical and biophysical research communications 2016, 478(1):323-329.
 Zhang C-Y, Yu M-S, Li X, Zhang Z, Han C-R, Yan B: Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017, 39(6):1010428317701311-1010428317701311.
 Liu X-H, Sun M, Nie F-Q, Ge Y-B, Zhang E-B, Yin D-D, et al: Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Molecular cancer 2014, 13:92-92.
 Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, et al: A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011, 147(2):358-369.
 Zhang W, Shi S, Jiang J, Li X, Lu H, Ren F: LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2017, 91:312-319.
 Agarwal S, Behring M, Kim HG, Bajpai P, Chakravarthi B, Gupta N, et al: Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model. Translational oncology 2020, 13(4):100754.
 Parashar D, Geethadevi A, Aure MR, Mishra J, George J, Chen C, et al: miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer. Cell reports 2019, 29(13):4389-4406.e4310.
 Wang H, Tan Z, Hu H, Liu H, Wu T, Zheng C, et al: microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1. BMC cancer 2019, 19(1):738-738.
 Li Z-Y, Yang L, Liu X-J, Wang X-Z, Pan Y-X, Luo J-M: The Long Noncoding RNA MEG3 and its Target miR-147 Regulate JAK/STAT Pathway in Advanced Chronic Myeloid Leukemia. EBioMedicine 2018, 34:61-75.
 Zhang X, Wu N, Wang J, Li Z: LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis. Journal of cellular and molecular medicine 2019, 23(10):6708-6719.
 Wang M, Li C, Zhang Y, Zhou X, Liu Y, Lu C: LncRNA MEG3-derived miR-361-5p regulate vascular smooth muscle cells proliferation and apoptosis by targeting ABCA1. American journal of translational research 2019, 11(6):3600-3609.
 Roger M, Chaussain JL, Bost M, Bozzola M, Colle M, Despert F, et al: Treatment of precocious puberty with LH-RH agonists. Multicenter study using D-Trp-6-LH-RH in a programmed-release form. Rev Fr Gynecol Obstet 1986, 81(5):297-305.
 Si X, Liu Y, Lv J, Ding H, Zhang XA, Shao L, et al: ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells. Oncotarget 2016, 7(15):20966-20980.
 Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y, et al: Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology 2010, 151(3):939-947.
 Li J, Bian E-B, He X-J, Ma C-C, Zong G, Wang H-L, et al: Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas. International journal of oncology 2016, 48(2):723-733.
 Peng W, Si S, Zhang Q, Li C, Zhao F, Wang F, et al: Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression. Journal of experimental & clinical cancer research : CR 2015, 34(1):79-79.
 Yan H, Rao J, Yuan J, Gao L, Huang W, Zhao L, et al: Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate ischemic neuronal death by targeting miR-21/PDCD4 signaling pathway. Cell death & disease 2017, 8(12):3211-3211.
 Zhou W, Zhang Y, Zhong C, Hu J, Hu H, Zhou D, et al: Decreased expression of TRIM21 indicates unfavorable outcome and promotes cell growth in breast cancer. Cancer management and research 2018, 10:3687-3696.
 Chen S-M, Wang B-Y, Lee C-H, Lee H-T, Li J-J, Hong G-C, et al: Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem/progenitor cells. Oncotarget 2017, 8(44):76057-76068.
 Wu Z, Qiu M, Guo Y, Zhao J, Liu Z, Wang H, et al: OTU deubiquitinase 4 is silenced and radiosensitizes non-small cell lung cancer cells via inhibiting DNA repair. Cancer cell international 2019, 19:99-99.
 Zhao Y, Majid MC, Soll JM, Brickner JR, Dango S, Mosammaparast N: Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase. The EMBO journal 2015, 34(12):1687-1703.